Alvac-HIV vCP205: NIH's AIDS vaccine evaluation group began a Phase I trial in 76 adults at low risk of HIV infection, with half of the volunteers required to h

Pasteur-Merieux/Connaught, Swiftwater, Penn.
Product: Alvac-HIV vCP205, weakened

Read the full 74 word article

How to gain access

Continue reading with a
two-week free trial.